An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects
Clinical trial NCT00144261 · COMPLETED
Trial details
- NCT number
- NCT00144261
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-11-01
- Primary completion
- 2006-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.